Shares of IntelliPharmaCeutics International (TSE I) opened at C$3.23 on Friday. The company has a market cap of $41.24, a price-to-earnings ratio of -7.51 and a beta of 0.61. IntelliPharmaCeutics International has a 52-week low of C$1.78 and a 52-week high of C$4.50.
About IntelliPharmaCeutics International
Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals.
Receive News & Ratings for IntelliPharmaCeutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelliPharmaCeutics International and related companies with MarketBeat.com's FREE daily email newsletter.